Risk factors for non- alcoholic fatty liver disease: a multivariate analysis

Pang XueQin; Chen WeiChang; Feng Huang; Tian WenYan

doi:10.3969/j.issn.1001-5256.2014.09.016

Issue 9

Sep. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(9): 903-905

PDF( 1308 KB)

Risk factors for non- alcoholic fatty liver disease: a multivariate analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.016

The First Affiliated Hospital of Soochow University

Received Date: 2013-11-08
Published Date: 2014-09-20

Abstract

Abstract

Objective To investigate the risk factors for non- alcoholic fatty liver disease ( NAFLD) and to provide a basis for the prevention of NAFLD. Methods A total of 190 patients with NAFLD who visited the First Affiliated Hospital of Soochow University from January2011 to January 2013 were included in the study. The investigated factors included sex, age, height, weight, dietary habit, smoking and alcohol consumption, educational level, occupation, intensity and duration of physical exercise, bedtime, previous history, and family history. Univariate and multivariate analyses were performed using SPSS 18. 0 to determine the risk factors for NAFLD. Results The univariate analysis showed that sex, age, dietary habit, occupation, body mass index ( BMI) , and educational level were associated with NAFLD ( P <0. 05) . The logistic regression analysis showed that the risk factors for NAFLD were sex ( OR = 5. 692, P = 0. 029) , age ( OR = 0. 423, P =0. 041) , occupation ( OR = 0. 698, P = 0. 008) , BMI ( OR = 3. 939, P = 0. 003) , educational level ( OR = 5. 463, P = 0. 030) , and dietary habit ( OR = 9. 235, P = 0. 039) . Conclusion NAFLD may be related to many factors, and corresponding preventive measures may reduce the development of NAFLD.
- fatty liver,
- risk factors,
- factor analysis, statistical,
- regression analysis

FullText(HTML)

References(13)

References

[1] LIU Y, DAI M, BI Y, et al.Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD) :a population-based study in China[J].J Epidemiol, 2013, 23 (2) :115-121.

[2]WANG J.Research advances in risk factors for fatty liver[J].Med J Chin People's Health, 2012, 24 (19) :2396-2398. (in Chinese) 王娟.脂肪肝相关因素的研究进展[J].中国民康医学, 2012, 24 (19) :2396-2398.

[3]HUANG H, BIAN ZL, WANG QX, et al.Cross sectional study on prevalence of fatty liver and its risk factors in community elderly of Shanghai[J].Chin Hepatol, 2012, 17 (8) :546-550. (in Chinese) 黄欢, 卞兆连, 王绮夏, 等.上海市社区60岁以上人群脂肪肝患病率及危险因素的横断面研究[J].肝脏, 2012, 17 (8) :546-550.

[4]Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[5]OU WY, DING H, CAI BQ, et al.Ultrasound clinical value in diagnosis of fatty liver[J].Heilongjiang Med J, 2011, 35 (6) :444-446. (in Chinese) 欧婉燕, 丁辉, 蔡碧琼, 等.超声在脂肪肝诊断中的临床价值[J].黑龙江医学, 2011, 35 (6) :444-446.

[6]GAO GY, GU Q.Research progress in Chinese medicine treatment of nonalcoholic fatty liver[J].J Changchun Univ Tradit Chin Med, 2012, 28 (2) :360-362. (in Chinese) 高广义, 顾勤.非酒精性脂肪肝的中医药治疗研究进展[J].长春中医药大学学报, 2012, 28 (2) :360-362.

[7]FAN JG, ZHU J, LI XJ, et al.Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai[J].Chin J Hepatol, 2005, 13 (2) :83-87. (in Chinese) 范建高, 朱军, 李新建, 等.上海市成人脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志, 2005, 13 (2) :83-87.

[8]HONG XM.Investigation of risk factors for development of fatty liver in middle-aged and young college teachers[J].Jiangsu Med J, 2004, 30 (12) :954-955. (in Chinese) 洪晓岷.高校中青年教师脂肪肝发病相关因素探讨[J].江苏医药, 2004, 30 (12) :954-955.

[9]KOPEC KL, BURNS D.Nonalcoholic fatty liver disease:a review of the spectrum of disease, diagnosis, and therapy[J].Nutr Clin Pract, 2011, 26 (5) :565-576.

[10]ZHANG J, CHEN YP, LI H, et al.Correlation between metabolic syndrome-related parameters and nonalcoholic fatty liver disease[J].Chin J Pract Intern Med, 2012, 32 (5) :356-359. (in Chinese) 张洁, 陈友鹏, 李虹, 等.非酒精性脂肪性肝病与代谢综合征指标变化的相关性分析[J].中国实用内科杂志, 2012, 32 (5) :356-359.

[11]TANG YZ.Association of fatty liver with age, BMI, and blood lipids[J].Mod Med Health, 2007, 23 (11) :1623-1624. (in Chinese) 唐永忠.脂肪肝与年龄体质量指数和血脂水平相关性分析[J].现代医药卫生, 2007, 23 (11) :1623-1624.

[12]YIN J, LI WP.Research advances in pathogenesis of nonalcoholic liver fatty disease[J].Sichuan J Physiol Sci, 2012, 34 (3) :126-130. (in Chinese) 殷杰, 李万平.非酒精性脂肪肝的发病机制研究进展[J].四川生理科学杂志, 2012, 34 (3) :126-130.

[13]JIANG YM, SHI JP.The progress of pharmacotherapy in non-alcoholic fatty liver disease[J].J Clin Hepatol, 2011, 27 (9) :986-990. (in Chinese) 蒋艳明, 施军平.非酒精性脂肪性肝病药物治疗进展[J].临床肝胆病杂志, 2011, 27 (9) :986-990.引证本文:PANG XQ, CHEN WC, FENG H, et al.Risk factors for non-alcoholic fatty liver disease:a multivariate analysis[J].J Clin Hepatol, 2014, 30 (9) :903-905. (in Chinese) 庞雪芹, 陈卫昌, 冯璜, 等.非酒精性脂肪性肝病发病的多因素分析[J].临床肝胆病杂志, 2014, 30 (9) :903-905.

Relative Articles

[1]	Yu ZHANG, Yongfeng YANG. Thinking of the pathological diagnosis of unexplained liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(3): 498-503. doi: 10.3969/j.issn.1001-5256.2023.03.003
[2]	Xixuan WANG, Liangzi DING, Yang CHENG, Hao HAN, Jian YANG, Jiangqiang XIAO, Yi WANG, Ming ZHANG, Feng ZHANG, Yuzheng ZHUGE. Value of liver stiffness measured by acoustic radiation force impulse in diagnosis of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2022, 38(11): 2488-2492. doi: 10.3969/j.issn.1001-5256.2022.11.010
[3]	Jialing ZHOU, Bingqiong WANG, Yameng SUN, Tongtong MENG, Shanshan WU, Hong MA, Xiaojuan OU, Hong YOU, Jidong JIA, Xiaoning WU. Application value of liver stiffness measurement-to-platelet ratio index score in diagnosis of hepatitis B liver fibrosis and liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1529-1533. doi: 10.3969/j.issn.1001-5256.2022.07.014
[4]	Zhongjie YU, Wenxia ZHAO, Leixin FENG, Hanxiao WANG, Jianpeng LIU. Value of five noninvasive diagnostic methods for liver cirrhosis in diagnosis of traditional Chinese medicine syndrome types in patients with compensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(1): 104-109. doi: 10.3969/j.issn.1001-5256.2022.01.016
[5]	Yajie XU, Wenzheng YOU, Wanlei REN, Quanhe LONG, Xiangjun JIANG, Doudou HU. Application of pathological indicators based on liver biopsy in the diagnosis of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2021, 37(12): 2935-2938. doi: 10.3969/j.issn.1001-5256.2021.12.042
[6]	Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004
[7]	NIU XingJie, LIU ZhiHui, CUI FengMei, LIU YaoMin, WANG YanFei, ZHANG GuoMin, LIU JinXia. Value of peripheral blood long non-coding RNA-LET in the diagnosis of chronic hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2709-2713. doi: 10.3969/j.issn.1001-5256.2020.12.014
[8]	Zhou ShengYun, Duan ZhiHui. Noninvasive diagnosis of esophageal varices in liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1842-1846. doi: 10.3969/j.issn.1001-5256.2020.08.036
[9]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2163-2172. doi: 10.3969/j.issn.1001-5256.2019.10.007
[10]	Li JiaNa, Zheng RuiQi, Li Na, Hu YuLin. The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1361-1364. doi: 10.3969/j.issn.1001-5256.2019.06.040
[11]	Zhang YaNan, Jiang Chang, Xu Ying, Gao YanHang. Early diagnosis of spontaneous bacterial peritonitis in liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1851-1853. doi: 10.3969/j.issn.1001-5256.2019.08.045
[12]	Liu HaiFeng, Xu YongSheng, Zhang Yue, Zhao XiaoJu, Liu Zhao, Li JinKui, Yan RuiFeng, Xu Kai, Lei JunQiang. Value of magnetic resonance morphological imaging in the diagnosis and differentiation of post-hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2587-2591. doi: 10.3969/j.issn.1001-5256.2018.12.016
[13]	Yang ErNa, Cao WuKui. Research advances in noninvasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2209-2213. doi: 10.3969/j.issn.1001-5256.2017.11.035
[14]	Du JingHua, Nan YueMin. Novel molecular diagnostic markers for liver fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 445-450. doi: 10.3969/j.issn.1001-5256.2017.03.009
[15]	Zhang Hui, Jia Lei, Lu: Dong, Xu YouQing. Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2118-2120. doi: 10.3969/j.issn.1001-5256.2016.11.022
[16]	Deng Han, Qi XingShun, Zhu Qiang, Guo XiaoZhong. Alternative methods for diagnosis of esophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(8): 1468-1473. doi: 10.3969/j.issn.1001-5256.2016.08.007
[17]	Zhao Wei. Clinical significance of plasma and urine neutrophil gelatinase-associated lipocalin levels in diagnosis of acute kindney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1874-1877. doi: 10.3969/j.issn.1001-5256.2015.11.025
[18]	Wang Shuai, Hu DaRong. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites[J]. Journal of Clinical Hepatology, 2015, 31(7): 1018-1022. doi: 10.3969/j.issn.1001-5256.2015.07.005
[19]	Cai JunJun, Han Tao. Diagnosis and treatment of acute kidney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1352-1356. doi: 10.3969/j.issn.1001-5256.2014.12.030
[20]	Jia KeDong, Shi ShuXian, Ruan YouBing. Detection of sialic acid in hepatitis involved liver cirrhosis and its significance for HCC diagnosis[J]. Journal of Clinical Hepatology, 2005, 21(2): 101-103.

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	朱亭亭，陈逸云，谢帆慈，李正鑫. 无创评估肝纤维化逆转研究进展. 实用肝脏病杂志. 2025(02): 169-172 .
2.	巴图德力根，韩志强，韩格根套丽，徐艳华，牧仁，安达. 德都红花-7味散及其主要成分对肝纤维化小鼠CCR1、DNMT1蛋白的作用研究. 中国临床药理学杂志. 2024(07): 1004-1008 .
3.	张永，李艺，张欢. 复肝消积汤联合恩替卡韦治疗乙肝肝硬化代偿期的临床观察. 中国中西医结合消化杂志. 2023(02): 100-103+109 .
4.	李定富，唐换灵，黄健，王秀琪. 血PⅢP、LN、HA水平与慢性肝炎程度、肝纤维化分期及炎症活动度分级的关系. 临床和实验医学杂志. 2022(10): 1119-1121 .
5.	何杰，余松，董金玲，陈燕. 复元活血汤治疗肝硬化疗效观察及对肝脏纤维化的影响. 新中医. 2021(18): 29-32 .
6.	刘沁雨，常越，张青，丁玉平，李海. 高尔基体蛋白73对抗病毒治疗慢性乙型肝炎患者代偿期肝硬化的诊断价值. 解放军医药杂志. 2020(03): 86-91 .

Other cited types(6)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2518) PDF downloads(547)

Risk factors for non- alcoholic fatty liver disease: a multivariate analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.016

Abstract

References

Relative Articles

Cited by

Periodical cited type(6)

Other cited types(6)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Risk factors for non- alcoholic fatty liver disease: a multivariate analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.016

Abstract

References

Relative Articles

Cited by

Periodical cited type(6)

Other cited types(6)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content